Invesco Biotechnology & Genome ETF
PBE
#2025
ETF rank
A$0.37 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$117.01
Share price
-1.00%
Change (1 day)
8.95%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of February 8, 2026

Number of holdings: 32

Full holdings list

Weight %NameTickerShares Held
5.90%
Gilead Sciences IncGILD103770
5.57%
Amgen IncAMGN38885
5.51%
Biogen IncBIIB73517
5.00%
Regeneron Pharmaceuticals IncREGN17072
4.94%
Incyte CorpINCY122358
4.93%
United Therapeutics CorpUTHR27241
4.60%
Illumina IncILMN103203
3.82%
Amicus Therapeutics IncFOLD716939
3.66%
Alnylam Pharmaceuticals IncALNY29936
3.58%
Dynavax Technologies CorpDVAX619803
2.98%
MannKind CorpMNKD1382171
2.97%
Royalty Pharma PLCRPRX178379
2.91%
Ionis Pharmaceuticals IncIONS90302
2.90%
Halozyme Therapeutics IncHALO95817
2.85%
QIAGEN NVQGEN150201.3786
2.78%
Bio-Techne CorpTECH111680
2.77%
BioMarin Pharmaceutical IncBMRN127758
2.76%
Collegium Pharmaceutical IncCOLL155580
2.75%
Catalyst Pharmaceuticals IncCPRX301597
2.74%
Exelixis IncEXEL167824
2.64%
Neurocrine Biosciences IncNBIX50198
2.60%
ACADIA Pharmaceuticals IncACAD296675
2.55%
Protagonist Therapeutics IncPTGX80859
2.47%
PTC Therapeutics IncPTCT88821
2.47%
BioCryst Pharmaceuticals IncBCRX1038146
2.46%
Vericel CorpVCEL182370
2.38%
TG Therapeutics IncTGTX221373
2.25%
Repligen CorpRGEN42392
2.15%
Madrigal Pharmaceuticals IncMDGL12061
2.05%
Veracyte IncVCYT151832
0.07%
Invesco Government & Agency PortfolioAGPXX189569.5
0.03%
CASH & EQUIVALENTSUSD84861.55